摘要
分枝杆菌的休眠被定义为应激反应中稳定但可逆的非复制阶段。在结核分枝杆菌(一种重要的人类病原体)中,这个阶段是潜伏性结核的原因。目前治疗结核的化疗尽管可以有效杀死生长的结核杆菌,但很大程度上无法杀死休眠菌。为此,近期研究的热点在于开发新药来对抗这种潜在形式的疾病。基于此目的,关于细菌从休眠中复苏的分子基础是必需和非常重要的。本文综述了当前从分枝杆菌休眠中退出的复杂机制的知识,描述了负责分枝杆菌从休眠中复苏的分子并从结构角度讨论了其作用。
关键词: 休眠,分枝杆菌,复苏,结构。
Current Medicinal Chemistry
Title:Exit from Mycobacterial Dormancy: A Structural Perspective
Volume: 22 Issue: 14
Author(s): Flavia Squeglia, Alessia Ruggiero and Rita Berisio
Affiliation:
关键词: 休眠,分枝杆菌,复苏,结构。
摘要: Dormancy in mycobacteria is defined as a stable but reversible non-replicating state in response to stresses. In Mycobacterium tuberculosis, an important human pathogen, this state is responsible for latent Tuberculosis. The current chemotherapy to defeat Tuberculosis while effective in killing growing tubercle bacilli is largely ineffective in killing dormant bacilli. For this reason there is a recent interest to develop new drugs against this disease in the latent form. To this aim, the knowledge of the molecular basis of bacterial resuscitation from dormancy is necessary and of paramount importance. This review summarizes the current knowledge on the complex mechanism of exit from mycobacterial dormancy; the main molecular players responsible for mycobacterial resuscitation from dormancy are described and their role is discussed from a structural perspective.
Export Options
About this article
Cite this article as:
Flavia Squeglia, Alessia Ruggiero and Rita Berisio , Exit from Mycobacterial Dormancy: A Structural Perspective, Current Medicinal Chemistry 2015; 22 (14) . https://dx.doi.org/10.2174/0929867322666150209153027
DOI https://dx.doi.org/10.2174/0929867322666150209153027 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bronchial Asthma and Lung Cancer
Current Respiratory Medicine Reviews Tumor Markers in Patients with Benign and Malignant Pulmonary Diseases; Competitive Evaluation of ProGRP, NSE and Cyfra 21-1
Recent Patents on Biomarkers Combined 3D-QSAR and molecular docking study for identification of diverse natural products as potent Pf ENR inhibitors
Current Computer-Aided Drug Design Synthesis and Evaluation of Antimicrobial Activity of Thiazolidinone Derivatives
Letters in Drug Design & Discovery Nanoemulsion for the Effective Treatment and Management of Anti-tubercular Drug Therapy
Recent Patents on Anti-Infective Drug Discovery Synthesis and Biological Activity of 3-(substitutedphenyl)- 6-(4-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cardiovascular and Pulmonary Manifestations of Systemic Lupus Erythematosus
Current Rheumatology Reviews Editorial [Hot Topic: In Silico (Guest Editor: Alexandre G. de Brevern)]
Infectious Disorders - Drug Targets Synthesis, Spectroscopic Characterization and Antimicrobial Activities of Benzoxazolone Derivatives
Medicinal Chemistry Molecular Determinants of Vascular Calcification: A Bench to Bedside View
Current Molecular Medicine Managing Febrile Illness in Malaria-endemic Areas: Developing Novel Diagnostics Using Host Immunological Signatures as Surrogate Markers of Infection
Current Immunology Reviews (Discontinued) Graphical Abstracts
Medicinal Chemistry Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
Anti-Cancer Agents in Medicinal Chemistry Virtual Screening of Drugs: Score Functions, Docking, and Drug Design
Current Computer-Aided Drug Design A Review on Pharmacological Properties of Coumarins
Mini-Reviews in Medicinal Chemistry Drug Approval Process – In United States of America, European Union and India: A Review
Applied Clinical Research, Clinical Trials and Regulatory Affairs The Genus Glycosmis [Rutaceae]: A Comprehensive Review on its Phytochemical and Pharmacological Perspectives
The Natural Products Journal Cytokines as a Therapeutic Target for Allergic Diseases: A Complex Picture
Current Pharmaceutical Design Antimicrobial Activities of Synthetic Arylidine Nicotinic and Isonicotinic Hydrazones
Letters in Drug Design & Discovery Mutation and Evolution of Antibiotic Resistance: Antibiotics as Promoters of Antibiotic Resistance?
Current Drug Targets